Hints and tips:
Related Special Reports
...“New cancer drugs don’t come around very often,” said Robert Ladner, who founded CV6 in Los Angeles but swapped the beaches of Santa Monica for the Belfast drizzle to develop the CV6-168 drug at Queen’s...
...The industry has been particularly frustrated that the UK pays much less than many other developed countries for drugs, culminating in a dispute last year about rebates drugmakers are required to pay the...
...France has been actively encouraging the reshoring of basic medicine supply, with a giant paracetamol factory set to open in the country next year....
...Amazon is being threatened with legal action from the US medicines watchdog over the sales of “unapproved” drugs on its online site, as the tech giant faces scrutiny while seeking to break further into the...
...The company has been working with the pharmaceutical giant GSK, focusing on immuno-oncology drugs....
...Amazon’s online pharmacy business is benefiting from the frenzied demand for anti-obesity drugs among Americans, according to the division’s head, in a boost to ecommerce giant’s bid to disrupt the $4tn...
...“Data, regulatory and commercial [progress are] all converging in an area where there is a giant unmet medical need.”...
...Last year, the search giant merged its internal AI unit Brain with DeepMind, in an effort to concentrate its efforts and resources in the fast-moving technology....
...“Telegram supports and facilitates online and offline crimes all over the world — it may be fraud, it may be gun sales, drugs sales, people sales even,” says David Maimon, professor in the department of...
...US pharma giant Eli Lilly is also expanding supplies of its weight loss drug Mounjaro, which the UK approved in November. Supply shortages are not limited to the UK....
...Companies: Updates are expected from Anglo-Swedish drug giant AstraZeneca, British American Tobacco, French lender Crédit Agricole, France’s L’Oréal, advertising company Publicis, Germany’s Siemens and Watches...
...J&J’s medtech division has outstripped the growth of the company’s drugs and diagnostics business, generating $30.4bn in sales last year, or 35 per cent of group revenues....
...Shares in Bayer have underperformed since the group’s €63bn takeover of US agrochemical giant Monsanto, which saddled the company with debt and exposed it to costly and drawn-out litigation over allegations...
...And: Bayer chief executive Bill Anderson has ruled out a fresh capital increase as he battles investor scepticism over his plan to turn around the indebted and litigation-stricken German drugs and pesticides...
...But while Rolls-Royce may have trounced Novo Nordisk in annual share price gains, the pharma giant — riding high on its drugs for obesity — retains bragging rights when it comes to size....
...Michela Tindera This new option from WeightWatchers is part of a giant change that the company has made recently....
...a few years ago he described as one of Berkshire Hathaway’s “four giants”....
...The drinks giant’s chief financial officer John Murphy told the Financial Times that Coca-Cola had not seen any discernible impact from the drugs and that it would continue to offer products for consumers...
...World hit by major health crisis as obesity drugs make people stop exercising As the world embraces GLP-1 obesity wonder drugs, the people next in line to get a prescription stop caring about dieting and...
...Such orphan drugs are expected to account for more than a third of global sales at industry giant Johnson & Johnson in 2028, according to data group Evaluate. The same is expected of rival AstraZeneca....
...Novo bulks up to boost sales of weight-loss drugs The Danish pharma giant Novo Nordisk has become Europe’s most valuable corporation by making drugs that help people lose weight....
...Since the number of murders began to jump in 2008 amid a crackdown on drug cartels, more than 400,000 people have been murdered, data from statistics agency INEGI shows....
...Last year Galderma received approval from the US Food and Drug Administration for two new injectibles — one that targets cheeks, the other “under-eye hollows”....
...In the internal note, a Google executive called search advertising “one of the world’s greatest business models ever created”, before adding that only “illicit businesses (cigarettes or drugs) . . . could...
...The “Granolas”, a recently coined acronym for Europe’s 11 best performing stocks, include the global obesity drug market leader, Novo Nordisk, chip technology company ASML and the food giant Nestlé....
International Edition